· 2018
· 2017
· 2016
· 2015
· 2014
· 2013
· 2012
· 2011
· 2010
· 2009
· 2008
· 2007
· 2006
· 2005
· 2004
· 2003
· 2002
· 2001
· 2000년 이전




2015

1. Correlation between orphan nuclear receptor Nurr1 expression and amyloid deposition in 5XFAD mice, an animal model of Alzheimer's disease. Moon M, Jeong I, Kim CH, Kim J, Lee PK, Mook-Jung I, Leblanc P, Kim KS. J Neurochem. 2015 Jan;132(2):254-62. doi: 10.1111/jnc.12935. Epub 2014 Sep 16.

 2. β-amyloid and α-synuclein cooperate to block SNARE-dependent vesicle fusion. Choi BK, Kim JY, Cha MY, Mook-Jung I, Shin YK, Lee NK Biochemistry.   2015 Mar 10;54(9):1831-40

3. The role of mitochondrial DNA mutation on neurodegenerative diseases. Moon-Yong Cha, Dong Kyu Kim, and Inhee Mook-Jung. Experimental & molecular medicine  2015 Mar 13;47:e150

4.   Acute ER stress regulates amyloid precursor protein processing through ubiquitin-dependent degradation. Jung, E. S., Hong, H., Kim, C., & Mook-Jung, I. Scientific reports. 2015 Mar 5;5:8805

5. Aβ-induced degradation of BMAL1 and CBP leads to circadian rhythm disruption in Alzheimer’s disease. Song, H., Moon, M., Choe, H. K., Han, D. H., Jang, C., Kim, A., ... &  Mook-Jung I.  Mol Neurodegener. 2015 Mar 19;10(1):13.

6. Inhibition of Glutaminyl Cyclase Ameliorates Amyloid Pathology in an Animal Model of Alzheimer's Disease via the Modulation of γ-Secretase Activity. Song H, Chang YJ, Moon M, Park SK, Tran PT, Hoang VH, Lee J, Mook-Jung I. J Alzheimers Dis. 2015;43(3):797-807.

7. Two-Photon Absorbing Dyes with Minimal Autofluorescence in Tissue Imaging: Application to in Vivo Imaging of Amyloid-β Plaques with a Negligible Background Signal. Kim D, Moon H, Baik SH, Singha S, Jun YW, Wang T, Kim KH, Park BS, Jung J, Mook-Jung I, Ahn KH. J Am Chem Soc. 2015 Jun 3;137(21):6781-9.

8. Special issue on neurodegenerative diseases and their therapeutic approaches. Kim J,  Mook-Jung I.  Exp Mol Med. 2015 Mar 13;47:e146.

9.  CR6-interacting factor 1 is a key regulator in Aβ-induced mitochondrial disruption and pathogenesis of Alzheimer's disease. Byun J, Son SM, Cha MY, Shong M, Hwang YJ, Kim Y, Ryu H, Moon M, Kim KS,  Mook-Jung I.  Cell Death Differ.  2015 Jun;22(6):959-73.

10. A phosphomimetic mutant TDP-43 (S409/410E) induces Drosha instability and cytotoxicity in Neuro 2A cells. Kim KY, Lee HW, Shim YM, Mook-Jung I, Jeon GS, Sung JJ. Biochem Biophys Res Commun. 2015 Aug 14;464(1):236-43.

11. MicroRNA-124 slows down the progression of Huntington's disease by promoting neurogenesis in the striatum. Liu T, Im W, Mook-Jung I, Kim M. Neural Regen Res. 2015 May;10(5):786-91. doi: 10.4103/1673-5374.156978.

12. Thrombospondin-1 prevents amyloid beta-mediated synaptic pathology in Alzheimer's disease. Son SM, Nam DW, Cha MY, Kim KH, Byun J, Ryu H, Mook-Jung I. Neurobiol Aging. 2015 Dec;36(12):3214-27.

13. LRRK2 G2019S mutation attenuates microglial motility by inhibiting focal adhesion kinase. Choi I, Kim B, Byun JW, Baik SH, Huh YH, Kim JH, Mook-Jung I, Song WK, Shin JH, Seo H, Suh YH, Jou I, Park SM, Kang HC, Joe EH. Nat Commun. 2015 Sep 14;6:8255. doi: 10.1038/ncomms9255.

14. Statins induce insulin-degrading enzyme secretion from astrocytes via an autophagy-based unconventional secretory pathway. Son SM, Kang S, Choi H, Mook-Jung I. Mol Neurodegener. 2015 Oct 31;10(1):56. doi: 10.1186/s13024-015-0054-3.

15. Mitochondrial ATP synthase activity is impaired by suppressed O-GlcNAcylation in Alzheimer's disease. Cha MY, Cho HJ, Kim C, Jung YO, Kang MJ, Murray ME, Hong HS, Choi YJ, Choi H, Kim DK, Choi H, Kim J, Dickson DW, Song HK, Cho JW, Yi EC, Kim J, Jin SM, Mook-Jung I. Hum Mol Genet. 2015 Nov 15;24(22):6492-504.

16Amyloid β-interacting partners in Alzheimer's disease: From accomplices to possible therapeutic targets. Han SH, Park JC, Mook-Jung I. Prog Neurobiol. 2015 Dec 22. pii: S0301-0082(15)30036-8.


  

 

 


 

 

 

 


 

 

 

 

 

 

 

 

 

 

 

 

 

Laboratory for Alzheimer's Disease Research,
#215 Biomedical Research Building, Seoul National University College of Medicine
28 Yeongeon-dong, Jongno-gu, Seoul 110-799, Korea. Tel) +82-2-3668-7636, Fax) +82-2-3672-7352